Diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Male - Caucasian - age 18-60 years - BMI is *23 and
Exclusion criteria
Exclusion criteria: - Documented CVD - Diabetes mellitus - Stage 2 hypertension (resting blood pressure >160/100 mmHg) - History of severe inflammatory conditions in the past 15 years - Recent infections - recent history ( 4 U/day, more than 3 days in a row - Use of medication potentially affection insulin sensitivity, microvascular function or inflammation - Use of anticoagulants (types Warfarin and Coumadin derivatives) that can increase the risk of bleeding during the muscle biopsy (exception is made for aspirin). - Malignancies (except those of the skin), renal and hepatic diseases. - Smoking - Recent (10%) changes in body weight.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional and inflammatory properties of PVAT will be quantified and correlations with whole-body and microvascular insulin sensitivity will be analysed. Vasoreactivity of skeletal muscle arterioles with and without perivascular adipose tissue will be studied. We will measure markers of low-grade systemic inflammation and adipocytokines (IL-6, IL-8, leptin, TNF-*, MCP-1, adiponectin, resistin and PAI-1, fibrinogen) . Pearson's and Spearman correlation analyses will be conducted as appropriate to select the variable that is best correlating with insulin sensitivity. step-wise multivariate linear regressions will be performed to examine the relations between two variables, controlling for anthropometry and systemic inflammation, and standardized betas (B) are reported. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pearson's and Spearman correlation analyses will be conducted as appropriate. Correlations of microvascular recruitment in the heart will be correlated in a regression analysis using PVAT properties, anthropometric properties and inflammatory properties. | — |
Countries
Netherlands